Gut Microbiome: Both a Friend and a Foe
We Need to Stay on the Gut Microbiome’s Good Side or Risk Microbiota Dysbiosis
Cell-Based, Cell-Free Patches for Cardio Repair
Cardiologists May Now Feel Differently about Quick Patch Ups
RNAi Therapeutics: To the Liver ... and Beyond
RNAi Therapy Components Are Surviving Degradation, Staying Potent, and Reaching More Targets Than Ever
Cell Therapy Production Moves to Factory Floor
Assembly Lines Are Preparing to Churn out Safe, Reliable, and Affordable Constructs
Audrey Chang Ph.D.
Audrey Chang, Ph.D., serves as head of development services, at the BioReliance® portfolio of MilliporeSigma.